China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release first quarter of year 2011 financial results before the market opens on Wednesday, May 11, 2011.
The Company will hold a conference call at 8:30 am ET on May 11, 2011 to discuss first quarter results of fiscal year 2011.  Listeners may access the call by dialing 866-783-2145 or 857-350-1604 for international callers, access code: 43412948. A webcast will also be available through CPHI's website at A replay of the call will be accessible from 12:30 PM May 11, 2011 through May 18, 2011 by dialing 888-286-8010 or 617-801-6888 for international callers, access code: 49458851.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc.
Editorial Message 
This site contains materials from other clearly stated media sources for the purpose of discussion stimulation and content enrichment among our members only. does not necessarily endorse their views or the accuracy of their content. For copyright infringement issues please contact